辅助性曲妥珠单抗治疗开始后的心脏和炎症生物标志物谱 - Suppr

Cardiac and inflammation biomarker profile after initiation of adjuvant trastuzumab therapy.

作者信息

Dhesy-Thind Sukhbinder, Kumar Vikaash, Snider-McNair Aidan, Shortt Colleen, Mukherjee Som D, Ellis Peter, Pond Gregory R, Kavsak Peter A

出版信息

Clin Chem. 2013 Jan;59(1):327-9. doi: 10.1373/clinchem.2012.192419. Epub 2012 Sep 20.

DOI:10.1373/clinchem.2012.192419

PMID:22997283

Abstract

摘要

相似文献

Cardiac and inflammation biomarker profile after initiation of adjuvant trastuzumab therapy.辅助性曲妥珠单抗治疗开始后的心脏和炎症生物标志物谱

Clin Chem. 2013 Jan;59(1):327-9. doi: 10.1373/clinchem.2012.192419. Epub 2012 Sep 20.

Adjuvant trastuzumab improves survival in early breast cancer.辅助性曲妥珠单抗可提高早期乳腺癌患者的生存率。

Lancet Oncol. 2014 Dec;15(13):e589. doi: 10.1016/S1470-2045(14)71110-6. Epub 2014 Oct 31.

[Update: adjuvant trastuzumab in HER2 positive breast cancer].[更新：HER2 阳性乳腺癌的辅助曲妥珠单抗治疗]

Harefuah. 2012 Jan;151(1):37-42, 61.

Is there a case for anti-HER2 therapy without chemotherapy in early breast cancer?早期乳腺癌中无化疗的抗 HER2 治疗是否可行？

Breast. 2011 Oct;20 Suppl 3:S158-61. doi: 10.1016/S0960-9776(11)70316-2.

Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands.在荷兰，曲妥珠单抗联合辅助化疗治疗非转移性乳腺癌的实施情况。

Breast Cancer Res Treat. 2011 Aug;129(1):229-33. doi: 10.1007/s10549-011-1451-0. Epub 2011 Mar 24.

The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.曲妥珠单抗辅助治疗人表皮生长因子受体 2 阳性乳腺癌患者中心脏生物标志物、组织速度和应变成像以及心脏磁共振成像在预测早期左心室功能障碍中的作用。

J Am Coll Cardiol. 2011 May 31;57(22):2263-70. doi: 10.1016/j.jacc.2010.11.063.

Adjuvant trastuzumab for breast cancer. A second look. Longer follow-up confirms improved overall survival.乳腺癌的辅助性曲妥珠单抗治疗：再审视。更长时间的随访证实总生存期得到改善。

Prescrire Int. 2012 Dec;21(133):285-7.

[Chinese HER2 positive early breast cancer trastuzumab adjuvant therapy: preliminary outcomes].[中国HER2阳性早期乳腺癌曲妥珠单抗辅助治疗：初步结果]

Zhonghua Yi Xue Za Zhi. 2012 Dec 18;92(47):3345-9.

[Trastuzumab in early breast cancer].[曲妥珠单抗用于早期乳腺癌]

Presse Med. 2013 Jul-Aug;42(7-8):1069-80. doi: 10.1016/j.lpm.2013.01.054. Epub 2013 Apr 8.

Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy.辅助性曲妥珠单抗在接受基于抗HER2新辅助治疗的患者中的作用。

Br J Cancer. 2015 Feb 17;112(4):630-5. doi: 10.1038/bjc.2014.647. Epub 2015 Jan 13.

引用本文的文献

Concentrations and agreement over 10 years with different assay versions and analyzers for troponin T and N-terminal pro-B-type natriuretic peptide.10年间不同检测版本和分析仪检测肌钙蛋白T及N末端B型利钠肽原的浓度及一致性

Clin Chem Lab Med. 2024 Dec 10;63(5):e121-e123. doi: 10.1515/cclm-2024-1382. Print 2025 Apr 28.

High-Sensitivity Cardiac Troponin I for Long-Term Cardiovascular Risk Stratification in a Cancer Clinic Population.高敏心肌肌钙蛋白I用于癌症门诊人群的长期心血管风险分层

JACC CardioOncol. 2024 Jan 16;6(1):136-138. doi: 10.1016/j.jaccao.2023.11.006. eCollection 2024 Feb.

D-Dimer Is a Predictive Factor of Cancer Therapeutics-Related Cardiac Dysfunction in Patients Treated With Cardiotoxic Chemotherapy.D-二聚体是接受心脏毒性化疗患者发生癌症治疗相关心脏功能障碍的预测因素。

Front Cardiovasc Med. 2022 Jan 21;8:807754. doi: 10.3389/fcvm.2021.807754. eCollection 2021.

Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.生物标志物在评估化疗引起的心脏毒性中的应用。

Clin Biochem. 2015 Mar;48(4-5):223-35. doi: 10.1016/j.clinbiochem.2014.10.013. Epub 2014 Nov 7.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiac and inflammation biomarker profile after initiation of adjuvant trastuzumab therapy.

作者信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献